Immediate Impact
1 from Science/Nature 63 standout
Citing Papers
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Rodney E. Bigler being referenced
Treatment planning for internal radionuclide therapy: three-dimensional dosimetry for nonuniformly distributed radionuclides.
1990
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rodney E. Bigler | 213 | 95 | 40 | 53 | 24 | 289 | |
| Gerald M. Christensen | 165 | 41 | 73 | 107 | 27 | 313 | |
| Kwon Soo Chun | 82 | 12 | 46 | 44 | 16 | 252 | |
| W. M. Dale | 52 | 25 | 74 | 28 | 20 | 254 | |
| Anna Lövqvist | 252 | 41 | 69 | 74 | 12 | 319 | |
| Chie Toramatsu | 125 | 177 | 23 | 184 | 25 | 310 | |
| Barry M. Bowen | 102 | 21 | 36 | 67 | 13 | 328 | |
| Genki Horitsugi | 171 | 35 | 32 | 80 | 23 | 315 | |
| C. V. Robinson | 67 | 18 | 46 | 35 | 10 | 214 | |
| R Ibarra | 41 | 81 | 98 | 88 | 16 | 334 | |
| Laura Guidoni | 78 | 18 | 199 | 25 | 27 | 334 |
All Works
Loading papers...